This inventor holds 1 USPTO granted patent. Top assignee: C4 Therapeutlcs, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Robert T. Yu
Introduction
Robert T. Yu is a prominent inventor based in Arlington, VA, known for his significant contributions to the field of biotechnology. He has developed innovative compounds that target specific proteins involved in cancer progression. His work is crucial in the ongoing fight against various forms of cancer.
Latest Patents
Robert T. Yu holds a patent for "Compounds for targeted degradation of RET." This patent describes compounds of Formula (I) that act as protein degradation-inducing moieties for the proto-oncogene tyrosine-protein kinase receptor (RET). These compounds can be utilized to treat disorders mediated by the RET protein, including cancers and tumors. His innovative approach offers new avenues for therapeutic interventions.
Career Highlights
Yu's career is marked by his dedication to advancing cancer treatment through targeted therapies. His work at C4 Therapeutics, Inc. has positioned him at the forefront of research in this critical area. His innovative mindset and commitment to scientific excellence have led to the development of groundbreaking solutions in oncology.
Collaborations
Robert T. Yu collaborates with esteemed colleagues, including James A. Henderson and Christopher G. Nasveschuk. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
Robert T. Yu's contributions to the field of biotechnology, particularly in cancer treatment, highlight his role as a leading inventor. His patented compounds represent a significant advancement in targeted therapies, showcasing the potential for improved patient outcomes. His work continues to inspire future innovations in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile